This website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
This Website Uses Cookies By closing this message or continuing to use our site, you agree to our cookie policy. Learn MoreThis website requires certain cookies to work and uses other cookies to help you have the best experience. By visiting this website, certain cookies have already been set, which you may delete and block. By closing this message or continuing to use our site, you agree to the use of cookies. Visit our updated privacy and cookie policy to learn more.
MCTC Holdings Launches Delivery System Development Program for TCH-V
Goal is to increase bioavailability of rare cannabinoid.
MCTC Holdings, Inc. has undertaken Project Varin, a program to develop new delivery systems for tetrahydrocannabivarin (THC-V), a rare cannabinoid found in Cannabis sativa purported to suppress appetite.
"THC-V is so rare and difficult to obtain, it is currently valued at around $500,000 per kilogram, which is approximately ten times the price of gold,” said Arman Tabatabaei, CEO of MCTC Holdings, Inc. “ In order for the marketplace to utilize this potentially beneficial exotic cannabinoid, new delivery systems will need to be developed to allow the amount of THC-V administered to be efficiently utilized by the human body. This issue of bioavailability has been a significant ongoing concern for the industry relative to many cannabinoids, but with the rarity of THC-V, the need for efficient delivery is hugely amplified. It is our goal to solve this pressing industry issue. Based on our already completed laboratory accomplishments and our patent-pending technologies, we believe this goal is within our reach."